Insights

More Articles Back to Article

DIA China 2021: Global Pharmaceutical Regulation Evolving and Modernizing to Protect Public Health

The Global Regulatory Modernization Town Hall at DIA China 2021 aligned with the conference theme of Integrating into Globalization, New Journey to Innovation as representatives from four major regulatory authorities–the (China) National Medical Products Administration (NMPA), the US Food & Drug Administration (FDA), the European Medicines Agency (EMA), and the (Japan) Pharmaceuticals and Medical Devices Agency (PMDA)–shared strategies for building regulatory capacity building during the next three to five years.